CVRx (CVRX) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TELA Bio (TELA) has outperformed CVRx (CVRX) over the past year, losing 31.4% versus a loss of 81.6%. Over five years, CVRX leads with a -89.3% price change compared with -91.7% for TELA. TELA Bio is the larger company by market cap ($46.5 million vs $42.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | TELA |
|---|---|---|
| Share price | $1.61 | $1.03 |
| Market cap | $42.76M | $46.50M |
| 1-day change | -4.46% | -1.90% |
| YTD return | -76.34% | -11.02% |
| 1-year return | -81.56% | -31.37% |
| 5-year return | -89.27% | -91.67% |
| EPS (TTM) | $-1.97 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $1.56 |
| 52-week low | $1.50 | $0.501 |
| Distance from 52-week high | -85.80% | -33.97% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +185.36% | +101.94% |
| Average volume | 922.12K | 214.83K |
| Shares outstanding | 26.64M | 45.14M |
| Employees | 223 | 218 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELA has outperformed CVRX by 50.2 percentage points over the past year.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Health Care · Medical/Dental Instruments · 223 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
CVRX vs TELA FAQ
Which is bigger, CVRx or TELA Bio?
TELA Bio (TELA) is larger, with a market capitalization of $46.50M compared with $42.76M for CVRx (CVRX).
Which stock has performed better over the past year, CVRX or TELA?
TELA returned -31.37% over the past 12 months, compared with -81.56% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and TELA Bio in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.